Stay updated on Nivolumab + Brentuximab Vedotin in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab + Brentuximab Vedotin in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab + Brentuximab Vedotin in Hodgkin Lymphoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.3 to v3.5.4, representing a maintenance update to the page’s version. No visible changes to study information or functionality are evident.
    Difference
    0.0%
    Check dated 2026-05-18T13:51:36.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    Updates the displayed ClinicalTrials.gov page revision version in the footer (from v3.5.2 to v3.5.3).
    Difference
    0.0%
    Check dated 2026-04-26T15:34:22.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Collaborator name updated from Ono Pharmaceutical Co. Ltd to Ono Pharmaceutical Co., Ltd. Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-19T13:55:35.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. This change does not modify the study information or page functionality.
    Difference
    0.0%
    Check dated 2026-03-21T20:23:12.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3; no substantive content changes are evident on the page.
    Difference
    0.0%
    Check dated 2026-03-07T12:50:54.000Z thumbnail image
  9. Check
    112 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.4.2, replacing the prior v3.4.1; this is a minor metadata update that does not affect trial information.
    Difference
    0.0%
    Check dated 2026-02-13T17:35:48.000Z thumbnail image

Stay in the know with updates to Nivolumab + Brentuximab Vedotin in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab + Brentuximab Vedotin in Hodgkin Lymphoma Clinical Trial page.